Parallel Advisors’s Tempest Therapeutics TPST Stock Holding History

Parallel Advisors’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20	Hold	18	–	–	﹤0.01%	3911
2026 Q1	$30	Hold	18	–	–	﹤0.01%	3807
2025 Q4	$52	Hold	18	–	–	﹤0.01%	3572
2025 Q3	$185	Hold	18	–	–	﹤0.01%	3447
2025 Q2	$122	Hold	18	–	–	﹤0.01%	3451
2025 Q1	$174	Hold	18	–	–	﹤0.01%	3401
2024 Q4	$197	Hold	18	–	–	﹤0.01%	3374
2024 Q3	$330	Hold	18	–	–	﹤0.01%	3233
2024 Q2	$517	Buy	+18	New	+$779	﹤0.01%	3089

Other funds holding TPST

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Parallel Advisors's TPST Position: Q2 2026 in Review

Parallel Advisors held its Tempest Therapeutics (TPST) position steady in Q2 2026 at 18 shares worth $20. The position accounts for ﹤0.01% of the portfolio, ranked #3911.

Parallel Advisors first reported a position in TPST in Q2 2024 and has held it in 9 quarters since. The position peaked at $517 in Q2 2024. 3 funds tracked by Wall St. Rank hold TPST as of Q2 2026.

Parallel Advisors held 18 shares of Tempest Therapeutics worth $20 as of Q2 2026.
Parallel Advisors left its Tempest Therapeutics share count unchanged in Q2 2026.
Tempest Therapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3911 holding.
Parallel Advisors first reported a position in Tempest Therapeutics in Q2 2024 and has held it in 9 quarters since.
Parallel Advisors's Tempest Therapeutics position peaked at $517 in Q2 2024.
3 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.